Trailing Arbutus - Ipilimumab Interaction Details

Interaction Details

There were no interactions found between Ipilimumab and Trailing Arbutus. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.

Still looking for more information about combining Ipilimumab and Trailing Arbutus? Ask Dr. Brian Staiger about it by contacting him directly.

Ipilimumab Overview

Ipilimumab injection is used alone or in combination with nivolumab (Opdivo) to treat certain types of melanoma (a type of skin cancer) that that has spread to other parts of the body or cannot be treated with surgery. It is also used alone to prevent melanoma from returning after surgery. Ipilimumab injection is also used in combination with nivolumab to treat certain types of renal cell cancer (a type of cancer that begins in the cells of the kidneys), colorectal cancer (cancer that begins in the large intestine), hepatocellular cancer (a type of liver cancer), esophageal cancer (cancer of the tube that connects your throat to your stomach), and malignant pleural mesothelioma (a type of cancer that affects the inside lining of the lungs and chest cavity). It is also used in combination with nivolumab and other chemotherapy medications to treat a certain type of lung cancer (non-small cell lung cancer, NSCLC). Ipilimumab injection is in a class of medications called monoclonal antibodies. It works by helping the body to slow or stop the growth of cancer cells.
Your doctor will review your specific type of cancer and past treatment history and other available treatments to determine if ipilimumab is right for you.

See More Information Regarding Ipilimumab Injection

Trailing Arbutus - More Interactions

Trailing Arbutus interacts with 0 drugs

Unknown 2750 Interactions

Interaction Rating Key

These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.

Major	The combined use of these agents is strongly discouraged as serious side effects or other negative outcomes could occur.
Moderate	Use cautiously under the care of a healthcare professional or avoid this combination. A significant interaction or negative outcome could occur.
Minor	Be aware that there is a chance of an interaction. Watch for warning signs of a potential interaction.
Unknown	No interactions have been reported or no interaction data is currently available.